Advertisement
Original article| Volume 23, ISSUE 7, P616-623, November 2001

West syndrome: the Philippine experience

      Abstract

      Aim: To provide information on the current status of West syndrome (WS) in the Philippines.
      Methods: This is a retrospective review of WS cases from January 1997 to December 1999 from two largest referral government institutions. A questionnaire interview survey on anticonvulsant usage was also conducted among practicing child neurologists.
      Results: Twelve patients diagnosed to have infantile spasms at 2–15 months were included, with a male:female ratio of 1:1. The proportion of WS cases among epileptic children under age 3 was 3.18%. The etiologies were idiopathic/cryptogenic in four (33%) and symptomatic in eight (66%). Symptomatic cases include hypoxic-ischemic encephalopathy, neonatal sepsis, bacterial meningitis, inborn error of metabolism, congenital brain anomaly and intracranial hemorrhage. Phenobarbital was the first line drug in 75% of cases. Other drugs used were valproic acid, clonazepam and pyridoxine. With a follow-up duration of 1–40 months, only three patients became seizure free and most had poor neurodevelopmental outcome. Among practicing child neurologists, the preferred ideal drug was adrenocorticotrophic hormone (ACTH) and valproic acid for idiopathic and symptomatic cases, respectively. However, in actual clinical practice valproic acid or prednisone was the initial drug used. Pyridoxine was usually added on.
      Conclusions: The proportion of WS in our patient population may not reflect the true prevalence in our country since our data came from a biased population, i.e. referral centers. A national statistics is currently not available. ACTH, which was perceived by most child neurologists as the ideal first line drug was not used primarily because it is unavailable and unaffordable. The poor seizure control and developmental outcome may be due to the treatment given or directly related to the etiology of WS.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aicardi J.
        Epilepsy in children. 2nd ed. Raven Press, New York, NY1994
      1. Browne T.R. Feldman R.G. Epilepsy diagnosis and management. Little, Brown and Co, Boston, MA1983
        • Bobele G.B.
        • Bodensteiner J.B.
        The treatment of infantile spasms by child neurologists.
        J Child Neurol. 1994; 9: 432-435
        • Appleton R.E.
        The treatment of infantile spasms by paediatric neurologists in United Kingdom and Ireland.
        Dev Med Child Neurol. 1996; 38: 278-279
        • Watanabe K.
        Medical treatment of West syndrome in Japan.
        J Child Neurol. 1995; 10: 143-147
        • Ito M.
        Current therapy for West syndrome in Japan.
        J Child Neurol. 2000; 5: 424-428